SCHEMBL485049

SCHEMBL485049

COC(=O)c1ccc2c(c1)C(NC(=O)c1ccccc1Cl)CCO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
SPTLC2 O15270 1/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 2/20 0.44
TP53 P04637 1/20 0.44
PKM P14618 1/20 0.44
WDR5 P61964 1/20 0.44
TSHR P16473 1/20 0.43
BRD4 O60885 2/20 0.43
CREBBP Q92793 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784581 1.00 ALDH1A1 (0.47) ALDH1A1SPTLC2MAPTKDM4EKMT2A
SCHEMBL803721 0.93 SPTLC2 (0.49) ALDH1A1SPTLC2MAPTKDM4EKMT2A
SCHEMBL484844 0.88 ALDH1A1 (0.49) ALDH1A1SPTLC2MAPTBRD4CREBBP
SCHEMBL784976 0.88 ALDH1A1 (0.49) ALDH1A1SPTLC2MAPTBRD4CREBBP
SCHEMBL15235419 0.84 ALDH1A1 (0.45) ALDH1A1SPTLC2MAPTKDM4EKMT2A
SCHEMBL13190008 0.84 ALDH1A1 (0.45) ALDH1A1SPTLC2MAPTKMT2APOLB
SCHEMBL883780 0.84 ALDH1A1 (0.45) ALDH1A1SPTLC2MAPTKMT2APOLB
SCHEMBL2816083 0.83 ALDH1A1 (0.44) ALDH1A1SPTLC2KDM4EKMT2APOLB
SCHEMBL803181 0.83 ALDH1A1 (0.44) ALDH1A1SPTLC2KDM4EKMT2APOLB
SCHEMBL784965 0.82 ALDH1A1 (0.58) ALDH1A1SPTLC2MAPTKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
CN-103097354-A Substituted benzamide compounds GRUENENTHAL CHEMIE 2013-05-08 CN disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885SPTLC2 3707/4885MAPT 4634/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885SPTLC2 3707/4885MAPT 4634/4885
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 ALDH1A1 1267/4885SPTLC2 4412/4885MAPT 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.